by Elec23 | Dec 5, 2025 | News&events
A new scientific paper authored by Emanuele Montomoli and Claudia Maria Trombetta has just been published in Expert Review of Vaccines: “High-dose influenza vaccine: enhanced protection for the elderly.” The review highlights the added value of the high-dose influenza...
by Elec23 | Dec 3, 2025 | News&events
VisMederi is pleased to announce the establishment of VisMederi America, a new company based in Cleveland that marks a strategic milestone in the Group’s expansion into the United States. The new entity aims to strengthen VisMederi’s international presence,...
by Elec23 | Nov 27, 2025 | News&events
VisMederi is once again included in the “Leader of Growth 2026” ranking compiled by Il Sole 24 Ore in collaboration with Statista, where it ranks among the Italian companies that have performed the best in terms of revenue growth and development over the...
by Elec23 | Nov 3, 2025 | News&events
A new milestone in bacterial vaccine research: after several years of intensive research, validation work, and cross-institutional collaboration, the study on the development and qualification of a Multiplex assay for Shigella has now been officially published on...
by Elec23 | Aug 5, 2025 | News&events
A new paper from our team is online. The paper dissects the use of pseudotyped viral vectors to study the antibody-mediated immune responses. The pseudotype technology is an important tool for the study of the neutralizing activity in vaccinology and virology, as well...
